The Investor Advisory Group is made up of a group of experts at the forefront of life sciences investment and partnering in Australia, and provides AusBiotech with guidance and advice on our current and future investment programmes and events.
Committee members:
- Dr Steve Burnell, Managing Director, Tenmile
- Dr Amanda Gillon, Senior Partner, Investment, Bioscience Managers
- Sarah Meibusch, Partner, OneVentures
- Michael Molinari, Managing Director, IP Group Australia
- Dr Chris Nave, Managing Director, Brandon Capital Partners
- Scott Power, Senior Research Analyst, Morgans Financial
- Steven Yatomi-Clarke, Chief Executive Officer and Managing Director, Prescient Therapeutics Limited